BridgeMD
Tests treatment safety and results for Alcohol Use Disorder
Official title A Pilot Study of Non-invasive Brain Stimulation to Boost the Efficacy of Psychotherapy in a Community Sample of People Who Drink Alcohol
ClinicalTrials.gov ID: NCT04770025
What this study is testing
- What it's testing
- The goal of this small (n=75) proof-of-concept randomized clinical trial is to test the effects of transcranial alternating current stimulation (tACS) during motivational interviewing (MI) sessions with participants who drink at above the low-risk level. Participants will be randomized to receive either MI with active stimulation, MI with sham stimulation, or a delayed treatment group that receives MI with no stimulation.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Self-identify as having problem drinking
- Right-handed
- Age 21-60 years
- AUDIT score indicating risky drinking
You likely can't join if
- Left-handed or ambidextrous
- Currently engaged in treatment for alcohol use disorder
- Receiving treatment for alcohol use disorder within the prior 12 months
- History of brain injury or neurological diagnosis
- Evidence of current psychosis
- Past-year substance use disorder other than alcohol, marijuana, or nicotine
See the full eligibility criteria
- Self-identify as having problem drinking
- Right-handed
- Age 21-60 years
- AUDIT score indicating risky drinking
- Left-handed or ambidextrous
- Currently engaged in treatment for alcohol use disorder
- Receiving treatment for alcohol use disorder within the prior 12 months
- History of brain injury or neurological diagnosis
- Evidence of current psychosis
- Past-year substance use disorder other than alcohol, marijuana, or nicotine
- Current or history of severe alcohol withdrawal
- MRI/tACS contraindications including pregnancy
- Impaired hearing (psychotherapy using American Sign Language is not possible within the scope of the proposed study)
- Insufficient corrected visual acuity to complete the assessment instruments
- Unable to read/speak English fluently
- Unable to provide valid informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Albuquerque, New Mexico, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Albuquerque, New Mexico, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.